Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helicobacter

Showing results (961-970 of 2,116) with videos related to

Pageof 212
Sort By:
Helicobacter|October 21, 2025
Cost-Effectiveness of Tailored vs. Empirical Therapy for H. pylori: A Decision-Tree AnalysisJoon Sung Kim, Hankil Lee, Yuri Jeong, et al.
Helicobacter|October 21, 2025
Tailored Therapy Guided by Antibiotic Genotypic Resistances and CYP2C19 Polymorphisms Detected From Fecal Specimens for the First-Line Helicobacter pylori Eradication: A Randomized Controlled TrialBaojun Suo, Xinlu Ren, Cailing Li, et al.
Helicobacter|June 18, 2020
Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug effluxYuying Cai, Caixia Wang, Zhenghong Chen, et al.
Helicobacter|August 18, 2016
Epidemiology of Helicobacter pylori infectionMārcis Leja, Anthony Axon, Hermann Brenner
Helicobacter|August 18, 2016
Diagnostic of Helicobacter pylori infectionFrancis Mégraud, Pauline Floch, Joachim Labenz, et al.
Helicobacter|August 18, 2016
Helicobacter pylori and extragastric diseasesElisabetta Goni, Francesco Franceschi
Helicobacter|April 22, 2020
PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysisCai-Ping Gao, Di Zhang, Ting Zhang, et al.
Helicobacter|September 22, 2025
Helicobacter pylori Pathogenic Factors and Their Interactions With the Gastric MicrobiomeCamilia Metadea Aji Savitri, Takashi Matsumoto, Kartika Afrida Fauzia, et al.
Helicobacter|September 25, 2025
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High-Dosage L. reuteri in H. pylori-Infected AdultsStefano Bibbò, Gustav Ahlström, Giovanni Mario Pes, et al.
Helicobacter|September 13, 2025
Impact of a FIT Based Colorectal Cancer Screening Program on Gastric Cancer Incidence, Early Diagnosis and Patients' SurvivalJoão Carlos Silva, Pedro Leite-Silva, Fernando Tavares, et al.
Pageof 212

Showing results (961-970 of 2,116) with videos related to

Sort By:
Pageof 212
Helicobacter|October 21, 2025
Cost-Effectiveness of Tailored vs. Empirical Therapy for H. pylori: A Decision-Tree AnalysisJoon Sung Kim, Hankil Lee, Yuri Jeong, et al.
Helicobacter|October 21, 2025
Tailored Therapy Guided by Antibiotic Genotypic Resistances and CYP2C19 Polymorphisms Detected From Fecal Specimens for the First-Line Helicobacter pylori Eradication: A Randomized Controlled TrialBaojun Suo, Xinlu Ren, Cailing Li, et al.
Helicobacter|June 18, 2020
Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug effluxYuying Cai, Caixia Wang, Zhenghong Chen, et al.
Helicobacter|August 18, 2016
Epidemiology of Helicobacter pylori infectionMārcis Leja, Anthony Axon, Hermann Brenner
Helicobacter|August 18, 2016
Diagnostic of Helicobacter pylori infectionFrancis Mégraud, Pauline Floch, Joachim Labenz, et al.
Helicobacter|August 18, 2016
Helicobacter pylori and extragastric diseasesElisabetta Goni, Francesco Franceschi
Helicobacter|April 22, 2020
PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysisCai-Ping Gao, Di Zhang, Ting Zhang, et al.
Helicobacter|September 22, 2025
Helicobacter pylori Pathogenic Factors and Their Interactions With the Gastric MicrobiomeCamilia Metadea Aji Savitri, Takashi Matsumoto, Kartika Afrida Fauzia, et al.
Helicobacter|September 25, 2025
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High-Dosage L. reuteri in H. pylori-Infected AdultsStefano Bibbò, Gustav Ahlström, Giovanni Mario Pes, et al.
Helicobacter|September 13, 2025
Impact of a FIT Based Colorectal Cancer Screening Program on Gastric Cancer Incidence, Early Diagnosis and Patients' SurvivalJoão Carlos Silva, Pedro Leite-Silva, Fernando Tavares, et al.
Pageof 212